Can post-mastectomy radiation therapy be omitted in T1-2 clinically node-negative breast cancer patients with a positive sentinel lymph node biopsy?

被引：0
|
作者：
Dinh, Kate [1 ]
Soran, Atilla [1 ]
Isik, Arda [1 ]
McAuliffe, Priscilla [1 ]
Diego, Emilia [1 ]
Sezgin, Efe [2 ]
Beriwal, Sushil [1 ]
Johnson, Ronald [1 ]
机构：
[1] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Pittsburgh, PA 15213 USA
[2] Izmir Inst Technol, Izmir, Turkey
来源：
ANNALS OF SURGICAL ONCOLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
581161
引用
收藏
页码：141 / 142
页数：2
相关论文
共 50 条
  • [41] Redefining prognosis in node-negative breast cancer: Can sentinel lymph node biopsy raise the threshold for systemic adjuvant therapy?
    Cody, HS
    Borgen, PI
    Tan, LK
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (03) : 227S - 230S
  • [42] Redefining prognosis in node-negative breast cancer: Can sentinel lymph node biopsy raise the threshold for systemic adjuvant therapy?
    Hiram S. Cody
    Patrick I. Borgen
    Lee K. Tan
    Annals of Surgical Oncology, 2004, 11 (Suppl 3) : 227S - 230S
  • [43] Is There A Role of Post-Mastectomy Radiotherapy for T1-2 Breast Cancer Patients with Node-Positive Pathology who Develop Pathologic Negative Lymph Nodes after Neoadjuvant Chemotherapy and Mastectomy?
    Wang, Q.
    Zhao, J. J.
    Han, X.
    Er, P.
    Meng, X.
    Shi, J.
    Sun, H.
    Zhu, J.
    Zhu, L.
    Wu, S.
    Zhang, W.
    Sun, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E49 - E49
  • [44] Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
    L. M. van Roozendaal
    B. Goorts
    M. Klinkert
    K. B. M. I. Keymeulen
    B. De Vries
    L. J. A. Strobbe
    C. A. P. Wauters
    Y. E. van Riet
    E. Degreef
    E. J. T. Rutgers
    J. Wesseling
    M. L. Smidt
    Breast Cancer Research and Treatment, 2016, 156 : 517 - 525
  • [45] Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
    Goorts, B.
    Van Roozendaal, L.
    Klinkert, M.
    Vane, M.
    De Vries, B.
    Strobbe, L.
    Wauters, C.
    Van Riet, Y.
    Degreef, E.
    Rutgers, E.
    Wesseling, J.
    Smidt, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S71 - S71
  • [46] Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
    van Roozendaal, L. M.
    Goorts, B.
    Klinkert, M.
    Keymeulen, K. B. M. I.
    De Vries, B.
    Strobbe, L. J. A.
    Wauters, C. A. P.
    van Riet, Y. E.
    Degreef, E.
    Rutgers, E. J. T.
    Wesseling, J.
    Smidt, M. L.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) : 517 - 525
  • [47] Sentinel lymph node biopsy should be considered for clinically node-negative breast cancer regardless of BRCA1/2 mutation status
    Huang, Xin
    Liu, Jia-Qi
    Zhou, Yi-Dong
    Xu, Ying
    Chen, Chang
    Wang, Xiang
    Cao, Xi
    Yao, Ru
    Sun, Qiang
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (18)
  • [48] Sentinel lymph node biopsy in older patients with breast cancer: Which subset can be omitted?
    Grand, M.
    Rapisarda, F.
    Giacchino, M.
    Farmer, L.
    Cook, L.
    Odofin, O.
    Sotheran, W.
    Ostrowski, M. M.
    Bonomi, R.
    Betal, D.
    ANNALS OF ONCOLOGY, 2022, 33 : S181 - S181
  • [49] Can sentinel lymph node biopsy be omitted in patients with clinical node negative before neoadjuvant chemotherapy
    Yoshida, T.
    Yoshida, A.
    Hayashi, N.
    Yamauchi, H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [50] Risk Factors Associated With Sentinel Lymph Node Metastasis in Clinically Node-Negative Breast Cancer
    Abdulla, Hussain Adnan
    Salman, Ahmed Zuhair
    Alaraibi, Sarah Jawad
    Nazzal, Khaled
    Ahmed, Sara Abdulameer
    Almahari, Sayed Ali
    Dhaif, Ali
    EUROPEAN JOURNAL OF BREAST HEALTH, 2023, 19 (03) : 229 - 234
12345